Immersive virtual reality is a powerful new tool that can help train patients in learning behavioral #VoiceTherapy techniques. Dr. Ümit Daşdöğen is leading research into the technology's potential for improving outcomes among these patients: mshs.co/3YwO1yZ #ENT

The SENTRY study, led by Dr. John Mascarenhas, is investigating the safety and efficacy of the combination of selinexor (Xpovio) plus ruxolitinib (Jakafi) for the treatment of patients with JAK inhibitor treatment-naive #myelofibrosis: mshs.co/3WCKLQ1 The Tisch Cancer Institute

Join Dr. Andrea Dunaif at the "Stakeholder Meeting to Develop Common Reference Ranges for Testosterone Tests in Women and Adolescent Girls." 🗓 Date: Monday, August 26, 2024 🕘 Time: 9:00 AM – 3:30 PM EDT Registration: mshs.co/3WF4gHz

The Multiomics2Targets, a new bioinformatics workflow developed by researchers from the Ma'ayan Lab, identifies drug targets for cohorts of #cancer patients profiled with multiomics assays. Learn more: mshs.co/3ApwLlf

Vote for the panel topic, "Revolutionizing Mental Healthcare with Implantable Devices," to be selected for the #SXSW 2025 agenda. This panel brings together experts in neuroscience, psychiatry, and advocacy to discuss innovative treatment approaches to depression:

Dr. Eyal Klang and his team tested generative #AI, specifically large language models (LLMs), against traditional #MachineLearning methods to predict whether patients who go to the ER need to be admitted, which had statistically similar results: mshs.co/3SKKysX

Congratulations Dr. Madeleine Ballard on this incredible achievement! Arnhold Institute for Global Health Institute for Health Metrics and Evaluation (IHME)

Our researchers published a paper in the New England Journal of Medicine, which showed that dupilumab resulted in histologic remission in a significantly higher percentage of children 1 to 11 years of age with eosinophilic esophagitis than placebo. This led to the first and only

Our scientists have identified a new class of RNAs, named "EV-UGRs," packed into tiny particles known as extracellular vesicles (EVs) that could revolutionize how cancer and other diseases are diagnosed. The team found that these molecules undergo changes when cancer is present,

A transformative research program is bringing medicine into the future. Learn how you can advance medicine from the comfort of your own home: mshs.co/3VARrig #Research #Medicine Charles Bronfman Inst for Personalized Medicine

Congratulations to Dr. Daria Lizneva on being named a finalist for the XSeed Award 2024 by the Cure for her groundbreaking work in developing a new small molecule for long-term #obesity management. Read how Dr. Lizneva's work can help millions of people: mshs.co/3XmVS13

We're excited to share the latest Mount Sinai Health System Department of Medicine 2023-24 Annual Report highlighting advances in clinical practice and research innovation spanning 14 divisions across seven hospitals in the New York metro area. Read the full report: mshs.co/3Z8SFna

In a new edition of ACC's Cardiology Hour, Dr. Valentin Fuster & a panel of experts break down the top trials released during #ESCCongress, such as HELIOS-B, OCEANIC-AF, EPIC-CAD, & more! 📽️: bit.ly/4e9yoBR #CardioX #CardioTwitter JACC Journals Mount Sinai Fuster Heart Hospital

In a new edition of ACC's Cardiology Hour, Dr. Valentin Fuster & a panel of experts break down the top trials released during #ESCCongress, such as HELIOS-B, OCEANIC-AF, EPIC-CAD, & more! 📽️: bit.ly/4e9yoBR #CardioX #CardioTwitter #JACC American College of Cardiology Mount Sinai Fuster Heart Hospital

We are proud to announce that the Office of Gender Equity in Science and Medicine at the Icahn School of Medicine at Mount Sinai is the recipient of the 2024 AAMC Group on Women in Medicine and Science Leadership Award for an Organization. The award recognizes its commitment to

This is a one-day conference on home dialysis sponsored by Icahn School of Medicine at Mount Sinai. This event brings together practitioners, researchers, clinician-scientists, and RNs, all experts in kidney disease, to discuss the latest advancements in Peritoneal Dialysis and

The SGLT2 inhibitor empagliflozin confers kidney-protective benefits and can therefore be given safely and effectively to patients when they are hospitalized for acute myocardial infarction (MI), according to a study led by Dr. Deepak L. Bhatt: mshs.co/3TbDYf6 #CardioX

Just out Science Magazine The aged immune system promotes cancer progression, implicating interleukin-1 ⍺ as a key mediator, as seen in old mice model and patients, with potential path for therapy science.org/doi/10.1126/sc… Miriam Merad, MD, PhD Lipschultz Precision Immunology Institute Icahn School of Medicine at Mount Sinai

Congratulations to Dr. Madeleine Ballard on being Institute for Health Metrics and Evaluation (IHME)'s 2024 #RouxPrize winner!

Thrilled to share our first study on aging from Miriam Merad, MD, PhD lab Icahn School of Medicine at Mount Sinai The Tisch Cancer Institute Lipschultz Precision Immunology Institute in which we demonstrate how aging promotes cancer. We show that: (1/n) science.org/doi/10.1126/sc…